rs6876890
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001044.5(SLC6A3):c.*972C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001044.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- classic dopamine transporter deficiency syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- SLC6A3-related dopamine transporter deficiency syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- parkinsonism-dystonia, infantileInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001044.5. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.207 AC: 25423AN: 122792Hom.: 3177 Cov.: 19 show subpopulations
GnomAD4 exome AF: 0.189 AC: 278AN: 1468Hom.: 48 Cov.: 0 AF XY: 0.179 AC XY: 158AN XY: 882 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.207 AC: 25449AN: 122868Hom.: 3187 Cov.: 19 AF XY: 0.203 AC XY: 12009AN XY: 59160 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.